Skip to main content
Figure 4 | Journal of Inflammation

Figure 4

From: Effect of the Cannabinoid Receptor-1 antagonist SR141716A on human adipocyte inflammatory profile and differentiation

Figure 4

SR141716A does not bind to TLR4, nor to TLR2. HEK-4-Blue (panel A) and HEK-2-Blue cells (panel B) were treated with SR141716A (100 nM and 200 nM), with or without their respective positive control: 10 ng/mL LPS and 1/100X Positive Control (PC), for 20 and 16 hours respectively. The graphs show the mean ± SD of the results of 2 experiments (n = 12 for each conditions).

Back to article page

Journal of Inflammation

ISSN: 1476-9255

Contact us